Research from the University of Aveiro creates influenza vaccine in tablets

A research team at the University of Aveiro is developing effervescent tablets to combat the influenza virus, a noninvasive method that may replace traditional vaccination, the academic source said today.

Effervescent tablets “contain egg yolk antibodies specific for the virus’s membrane-bound proteins, supplemented with vitamin C and other minerals to boost the immune system,” explains a university textbook on the research project.

It is a method that can be used by the whole population and not only by patients at risk, and has the advantage of being non-invasive compared to traditional vaccination,” said the research team.

The “secret” of the tablets, made with vitamin C and various minerals, is in the antibodies taken from the egg yolks of the chickens.

Without the contraindications of vaccines that have to be reformulated every year and without the invasive needle, the tablets developed by the University of Aveiro project, which hopes to obtain funding, is a means “capable of revolutionizing the fight against influenza.

Igy antibodies (so-called key ingredients of effervescent tablets) are produced exclusively by birds, being concentrated in the egg yolks.

They are proteins that act in the immune system as defenders of the organism and it is possible to manipulate them in order to make them effective weapons in the fight against Influenza, the virus that causes influenza, according to the researchers of the Department of Chemistry (DQ) of the University of Aveiro.

The idea of incorporating ‘igy’ antibodies into effervescent tablets was developed by Marguerita Rosa, Emanuel Capela and Mariam Kholany, PhD students in Chemical Engineering from the Department of Chemistry and the Institute of Materials of Aveiro, UA (CICECO).

One tablet a day is what we want to achieve to maintain the protection over time of increased incidence of the influenza virus,” the researchers note, hoping that these antibodies ” will not spur inflammatory reactions in the human immune system, passively decreasing viral load of the affected person“.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
error: Content is protected !!